Learn more about data supporting guidelines, recommendations and recent advances regarding therapeutic options for patients with solid tumors and malignant and nonmalignant hematologic disorders.
On completing the program, learners will gain a deeper understanding of the pathogenesis, diagnostic evaluation and therapeutic modalities available for a breadth of solid tumors and hematologic disorders, and the ability to integrate guideline-based treatments, new therapeutic modalities and diagnostic approaches into clinical practice.
This educational program is intended for physicians, advanced practice providers, nurses, pharmacists, residents and fellows interested in a comprehensive update on solid tumors and hematologic disorders, and will be of interest to those certifying or re-certifying for their boards.
Learners will attend the accredited, multi-day program in Seattle, WA on the dates in accordance with their package:
Learners will also have access to the session recordings 4-6 weeks after the event. Learners may only claim credit for the in-person sessions.
For questions or comments, contact Fred Hutchinson Cancer Center.
Fred Hutchinson Cancer Center — formed by the merger of Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center — and the University of Washington School of Medicine are pleased to offer our 13th Annual Comprehensive Hematology and Oncology Review Course as both an in-person and on-demand course.